↓ Skip to main content

DICE: Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian cancer resistant to standard treatment—a study protocol for a randomised trial investigating a novel therapy called TAK228

Overview of attention for article published in Trials, April 2022
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
DICE: Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian cancer resistant to standard treatment—a study protocol for a randomised trial investigating a novel therapy called TAK228
Published in
Trials, April 2022
DOI 10.1186/s13063-022-06201-3
Pubmed ID
Authors

Francesca Fiorentino, Jonathan Krell, Consuelo Nohpal de la Rosa, Lee Webber

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 17%
Student > Bachelor 2 11%
Student > Ph. D. Student 1 6%
Unknown 12 67%
Readers by discipline Count As %
Medicine and Dentistry 2 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Business, Management and Accounting 1 6%
Agricultural and Biological Sciences 1 6%
Nursing and Health Professions 1 6%
Other 2 11%
Unknown 10 56%